Literature DB >> 23131496

Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control.

Diana I Gomez1, Marcel Twahirwa, Larry S Schlesinger, Blanca I Restrepo.   

Abstract

The re-emerging importance of type 2 diabetes mellitus (DM) to tuberculosis (TB) control is of growing concern, but the basis for this relationship is poorly understood. Given the importance of mononuclear phagocytes for TB control and the reported alterations in monocytes of DM patients, we evaluated whether the initial interaction between both was affected in diabetics. Mycobacterium tuberculosis-naïve individuals with and without DM were group matched by age and gender and the efficiency of M. tuberculosis association (attachment and ingestion) with their monocytes was assessed in the presence of autologous serum. The association of M. tuberculosis with monocytes was significantly lower in diabetics (19.2 ± 6.1) than non-diabetics (27.5 ± 7.9; p = 0.02). Multivariate analysis controlling for host socio demographics, DM characteristics and serum lipids indicated that male gender (p = 0.04) and poorly-controlled DM (high HbA1c and hyperglycemia; p = 0.01) were significantly associated with the lower interaction of M. tuberculosis with monocytes. Serum heat-inactivation reduced the association of M. tuberculosis to similar levels in both study groups (p = 0.69) suggesting alterations in the complement pathway of DM patients. These findings suggest an altered route of entry of the pathogen in DM patients that may influence the downstream activation of signaling pathways in the monocyte and the survival of mycobacteria.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23131496      PMCID: PMC3580120          DOI: 10.1016/j.tube.2012.10.003

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   2.973


  37 in total

Review 1.  Entry of Mycobacterium tuberculosis into mononuclear phagocytes.

Authors:  L S Schlesinger
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

2.  Mycobacterium tuberculosis and the complement system.

Authors:  L S Schlesinger
Journal:  Trends Microbiol       Date:  1998-02       Impact factor: 17.079

Review 3.  Molecular organization and function of the complement system.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Phagocytotic activity of monocytes from diabetic patients.

Authors:  S Katz; B Klein; I Elian; P Fishman; M Djaldetti
Journal:  Diabetes Care       Date:  1983 Sep-Oct       Impact factor: 19.112

5.  Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes.

Authors:  Yong Ding; Alpdogan Kantarci; Hatice Hasturk; Philip C Trackman; Alan Malabanan; Thomas E Van Dyke
Journal:  J Leukoc Biol       Date:  2006-11-09       Impact factor: 4.962

6.  Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonising proteins.

Authors:  N J Davidson; J M Sowden; J Fletcher
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

7.  Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus.

Authors:  F Y Chang; M F Shaio
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

8.  Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus.

Authors:  Pamela S Hair; Charlene G Echague; Reuben D Rohn; Neel K Krishna; Julius O Nyalwidhe; Kenji M Cunnion
Journal:  J Transl Med       Date:  2012-03-05       Impact factor: 5.531

9.  Selective suppression of interleukin-12 induction after macrophage receptor ligation.

Authors:  F S Sutterwala; G J Noel; R Clynes; D M Mosser
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

10.  CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes.

Authors:  Takuya Komura; Yoshio Sakai; Masao Honda; Toshinari Takamura; Kouji Matsushima; Shuichi Kaneko
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

View more
  43 in total

Review 1.  Diabetes and Tuberculosis.

Authors:  Blanca I Restrepo
Journal:  Microbiol Spectr       Date:  2016-12

Review 2.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 3.  Diabetes and immunity to tuberculosis.

Authors:  Nuria Martinez; Hardy Kornfeld
Journal:  Eur J Immunol       Date:  2014-02-16       Impact factor: 5.532

4.  Modulation of iron status biomarkers in tuberculosis-diabetes co-morbidity.

Authors:  Nathella Pavan Kumar; Vaithilingam V Banurekha; Dina Nair; Chandrakumar Dolla; Paul Kumaran; Subash Babu
Journal:  Tuberculosis (Edinb)       Date:  2017-11-24       Impact factor: 3.131

5.  Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.

Authors:  Omamah Alfarisi; Vidya Mave; Sanjay Gaikwad; Tushar Sahasrabudhe; Geetha Ramachandran; Hemanth Kumar; Nikhil Gupte; Vandana Kulkarni; Sona Deshmukh; Sachin Atre; Swapnil Raskar; Rahul Lokhande; Madhusudan Barthwal; Arjun Kakrani; Sandy Chon; Amita Gupta; Jonathan E Golub; Kelly E Dooley
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 6.  The re-emerging association between tuberculosis and diabetes: Lessons from past centuries.

Authors:  Jose Cadena; Selvalakshmi Rathinavelu; Juan C Lopez-Alvarenga; Blanca I Restrepo
Journal:  Tuberculosis (Edinb)       Date:  2019-05-03       Impact factor: 3.131

Review 7.  New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics.

Authors:  Thomas R Hawn; Javeed A Shah; Daniel Kalman
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

8.  Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Shanmugam Sivakumar; Pradeep A Menon; Vijay Viswanathan; Hardy Kornfeld; Subash Babu
Journal:  Tuberculosis (Edinb)       Date:  2016-10-11       Impact factor: 3.131

Review 9.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms.

Authors:  Katharina Ronacher; Reinout van Crevel; Julia A Critchley; Andrew A Bremer; Larry S Schlesinger; Anil Kapur; Randall Basaraba; Hardy Kornfeld; Blanca I Restrepo
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

Review 10.  Impact of diabetes on the natural history of tuberculosis.

Authors:  Blanca I Restrepo; Larry S Schlesinger
Journal:  Diabetes Res Clin Pract       Date:  2014-07-14       Impact factor: 5.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.